/Investor DB

Ascension Ventures — 2017 Investments

4 investments dated 2017 · listed companies and verified rows first · show all

Blokurblokur.comOct 2017 · $1.2M

Blokur operates a music rights conflict platform that enables music publishers and users to identify and manage ownership disputes and conflicts across songs and rights holders.

Marketing TechMedia & EntertainmentLondon, GB

Phil Barry(Founder)in

Co-investorsDigital Currency GroupFrontline VenturesMidOcean

Ivantis Incivantisinc.comSeries B · Jan 2017 · $27MAcquired

Ivantis was a medical device company founded in 2007 in Irvine, California, that developed the Hydrus Microstent, a minimally invasive device for treating glaucoma during cataract surgery.

Irvine, US

David Van Meter(Executive Officer, Director)

BoardTara Butler(Director)Douglas Roeder(Director)Ali Behbahani(Director)inRandy Alexander(Director)Thong Yuen Poon(Director)

Co-investorsForesite CapitalRA CapitalMemorialCare Innovation FundNew Enterprise Associates (NEA)

Renoviarenoviainc.comJan 2017 · $17M

Axena Health is a women's health company providing non-invasive, clinically tested treatments for pelvic health conditions.

Digital HealthFemTechMedical DevicesBoston, US

Jim O'Connor(Executive Officer)Eileen Maus(Executive Officer, Director)

BoardTara Butler(Director)Rich Aldrich(Director)inAdam Stone(Director)Dan Levangie(Director)

Co-investorsWestern Technology InvestmentLongwood FundOSF Ventures

Reputation Comreputation.comin𝕏Series A · Jan 2017 · $22M

Reputation is a reputation management software platform that analyzes reviews, listings, and surveys to deliver actionable insights for businesses managing their online presence across multiple locations.

Enterprise SoftwareMarketing TechSaaS

Joe BurtoninMichael Fertik(Founder)

Co-investorsAkkadian VenturesAugust CapitalBessemer Venture PartnersHeritage GroupIcon VenturesKickstart+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.